Angelini Pharma is expanding their existing product portfolio to now include Keneric Healthcare’s RTD™ Wound Dressing (antibacterial/antifungal).
Al Henry, CEO, Keneric Healthcare stated, “Our decision to combine efforts with Angelini to further promote our RTD™ antimicrobial dressing will further increase the number of patients and practitioners that can experience RTD™s proven efficacy.”
Todd Maddock, the CEO of Angelini U.S. stated, “We are excited to add Keneric’s RTD Dressing to our product portfolio. We look to provide healthcare professionals and patients with a range of wound treatment options based on innovative technologies like Keneric’s RTD™ Wound Dressing.”
Keneric Healthcare is a medical device company, headquartered in Irving, Texas, that is recognized by healthcare executives and clinicians alike for the development of innovative products that improve care, increase clinician efficiency and streamline facility expenditures.
Angelini is a privately-held, mid-sized international manufacturer and marketer of pharmaceutical and healthcare products in the pharmaceutical, infection control, wound care, dialysis, and mass-market segments.